Cargando…

In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors

Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom‐based study was completed, aimed at developing a system f...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnaghy, Sarah J., Deshpande, Shrikant, Cutajar, Dean L., Berk, Kemal, Metcalfe, Peter, Rosenfeld, Anatoly B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690127/
https://www.ncbi.nlm.nih.gov/pubmed/26103477
http://dx.doi.org/10.1120/jacmp.v16i3.5113
_version_ 1783279536060760064
author Alnaghy, Sarah J.
Deshpande, Shrikant
Cutajar, Dean L.
Berk, Kemal
Metcalfe, Peter
Rosenfeld, Anatoly B.
author_facet Alnaghy, Sarah J.
Deshpande, Shrikant
Cutajar, Dean L.
Berk, Kemal
Metcalfe, Peter
Rosenfeld, Anatoly B.
author_sort Alnaghy, Sarah J.
collection PubMed
description Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom‐based study was completed, aimed at developing a system for measurement of anterior rectal wall doses during hypofractionated prostate stereotactic body radiotherapy (SBRT) utilizing tomotherapy delivery. An array of four dual MOSkin™ dosimeters, spaced 1 cm apart, was placed on a replica Rectafix® immobilization spacer device. This Perspex probe is a more rigid alternative to rectal balloons, to improve geometric reproducibility. The doses at each point were measured in real time and compared to doses calculated by the treatment planning system (TPS). Additionally, distance‐to‐agreement (DTA) measurements were acquired to assist in the comparison of measured and predicted doses. All dual MOSkin detectors measured dose to within [Formula: see text] of the TPS at the anterior rectal wall. Whilst several points were outside of experimental error, the largest deviation from the TPS predicted dose represented a DTA of only 1.3 mm, within the acceptable DTA tolerance of 3 mm. Larger deviations of up to −11.9% were observed for the posterior and side walls; however, if acceptable DTA measurements are accounted for, then an agreement of 75% was observed. Although larger differences were observed at the other rectal wall locations, the overall effect of dose at these points was not as significant, given the lower doses. Despite the very high‐dose gradient region, real‐time measurements of the anterior rectal wall doses were within acceptable limits of TPS‐predicted doses. The differences between measured and planned data were due to difficulties in precisely locating each detector on the TPS dose grid, which presented large variations in dose between CT voxels in regions of steep dose gradients. The dual MOSkin system would, therefore, be a useful device for detecting errors in real time, such as patient shifts or incorrect setup, during tomotherapy of the prostate. PACS numbers: 87.53.Ly, 87.55.km, 87.55.N‐
format Online
Article
Text
id pubmed-5690127
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56901272018-04-02 In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors Alnaghy, Sarah J. Deshpande, Shrikant Cutajar, Dean L. Berk, Kemal Metcalfe, Peter Rosenfeld, Anatoly B. J Appl Clin Med Phys Radiation Oncology Physics Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom‐based study was completed, aimed at developing a system for measurement of anterior rectal wall doses during hypofractionated prostate stereotactic body radiotherapy (SBRT) utilizing tomotherapy delivery. An array of four dual MOSkin™ dosimeters, spaced 1 cm apart, was placed on a replica Rectafix® immobilization spacer device. This Perspex probe is a more rigid alternative to rectal balloons, to improve geometric reproducibility. The doses at each point were measured in real time and compared to doses calculated by the treatment planning system (TPS). Additionally, distance‐to‐agreement (DTA) measurements were acquired to assist in the comparison of measured and predicted doses. All dual MOSkin detectors measured dose to within [Formula: see text] of the TPS at the anterior rectal wall. Whilst several points were outside of experimental error, the largest deviation from the TPS predicted dose represented a DTA of only 1.3 mm, within the acceptable DTA tolerance of 3 mm. Larger deviations of up to −11.9% were observed for the posterior and side walls; however, if acceptable DTA measurements are accounted for, then an agreement of 75% was observed. Although larger differences were observed at the other rectal wall locations, the overall effect of dose at these points was not as significant, given the lower doses. Despite the very high‐dose gradient region, real‐time measurements of the anterior rectal wall doses were within acceptable limits of TPS‐predicted doses. The differences between measured and planned data were due to difficulties in precisely locating each detector on the TPS dose grid, which presented large variations in dose between CT voxels in regions of steep dose gradients. The dual MOSkin system would, therefore, be a useful device for detecting errors in real time, such as patient shifts or incorrect setup, during tomotherapy of the prostate. PACS numbers: 87.53.Ly, 87.55.km, 87.55.N‐ John Wiley and Sons Inc. 2015-05-08 /pmc/articles/PMC5690127/ /pubmed/26103477 http://dx.doi.org/10.1120/jacmp.v16i3.5113 Text en © 2015 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Alnaghy, Sarah J.
Deshpande, Shrikant
Cutajar, Dean L.
Berk, Kemal
Metcalfe, Peter
Rosenfeld, Anatoly B.
In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title_full In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title_fullStr In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title_full_unstemmed In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title_short In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors
title_sort in vivo endorectal dosimetry of prostate tomotherapy using dual moskin detectors
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690127/
https://www.ncbi.nlm.nih.gov/pubmed/26103477
http://dx.doi.org/10.1120/jacmp.v16i3.5113
work_keys_str_mv AT alnaghysarahj invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors
AT deshpandeshrikant invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors
AT cutajardeanl invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors
AT berkkemal invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors
AT metcalfepeter invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors
AT rosenfeldanatolyb invivoendorectaldosimetryofprostatetomotherapyusingdualmoskindetectors